Breathing With a Facemask Exercise Performance
Measuring Exercise Performance and Perception With Facemask Resistance
1 other identifier
observational
52
1 country
1
Brief Summary
This study will determine the dyspnea response in chronic lung disease volunteers during treadmill walking with and without added inspiratory resistance. This study will also determine the level of dyspnea and exercise sense of effort in individuals walking on a treadmill when elevations occur. Comparisons will be made of a participant's exercise response with and without increased inspiratory resistance. In this study, exercise performance will be analyzed based on physiological and perceptual measures. The participant will undergo two sessions: one session will be a standard exercise walking test without an inspiratory resistance; the other session will be the same standard exercise walking test while breathing with an inspiratory resistance equal to a N95 facemask (R=10-15 cmH2O/L/sec). Performance will be determined by physiological measures. Perception will be determined by scores based on numerical scales and automatically with the forehead Vitality remote monitoring sensor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2022
CompletedStudy Start
First participant enrolled
November 29, 2022
CompletedFirst Posted
Study publicly available on registry
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2024
CompletedOctober 15, 2025
October 1, 2025
1 year
November 21, 2022
October 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between dyspnea as measured by the device and reported dyspnea by subjects
2 hours
Study Arms (2)
Pulmonary Rehab Patients
Patients who attend respiratory therapy at John Muir Pulmonary Rehab facility
Control
Healthy adults, 18+
Interventions
Small forehead wearable and mobile app
Eligibility Criteria
Patients undergoing respiratory therapy at John Muir Health which encompasses a variety of pulmonary conditions
You may qualify if:
- Former pulmonary rehabilitation patients that are now participating in maintenance exercise classes
- Males and females with an age range of 18 years or older
- Subjects must be able to walk on treadmill for multiple sessions
You may not qualify if:
- The subjects in each experiment will be recruited for a distribution of gender, ethnicity and age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CereVu Medical, Inc.lead
- John Muir Healthcollaborator
Study Sites (1)
John Muir Health
Pleasant Hill, California, 94523, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Alireza Akhbardeh, PhD
CereVu Medical
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2022
First Posted
December 1, 2022
Study Start
November 29, 2022
Primary Completion
December 17, 2023
Study Completion
September 17, 2024
Last Updated
October 15, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share